JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB77528

Anti-YKL-40/CHI3L1 antibody

4

(3 Reviews)

|

(39 Publications)

Rabbit Polyclonal YKL-40/CHI3L1 antibody. Suitable for IHC-P, ICC/IF, WB and reacts with Human samples. Cited in 39 publications.

View Alternative Names

Chitinase-3-like protein 1, 39 kDa synovial protein, Cartilage glycoprotein 39, YKL-40, CGP-39, GP-39, hCGP-39, CHI3L1

4 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-YKL-40/CHI3L1 antibody (AB77528)
  • IHC-P

Ap

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-YKL-40/CHI3L1 antibody (AB77528)

IHC image of YKL-40/CHI3L1 staining in Human normal tonsil formalin fixed paraffin embedded tissue section, performed on a Leica Bond™ system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab77528, 1μg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

Immunocytochemistry/ Immunofluorescence - Anti-YKL-40/CHI3L1 antibody (AB77528)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-YKL-40/CHI3L1 antibody (AB77528)

ab77528 staining Chitinase-3-like protein 1 precursor in U-87 MG cells. The cells were fixed with 100% methanol (5 min), permeabilized with 0.1% PBS-Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1%PBS-Tween for 1h. The cells were then incubated overnight at 4°C with ab77528 at 5µg/ml and ab7291, Mouse monoclonal [DM1A] to alpha Tubulin - Loading Control. Cells were then incubated with ab150081, Goat polyclonal Secondary Antibody to Rabbit IgG - H&L (Alexa Fluor® 488), pre-adsorbed at 1/1000 dilution (shown in green) and ab150120, Goat polyclonal Secondary Antibody to Mouse IgG - H&L (Alexa Fluor® 594), pre-adsorbed at 1/1000 dilution (shown in pseudocolour red). Nuclear DNA was labelled with DAPI (shown in blue).

Western blot - Anti-YKL-40/CHI3L1 antibody (AB77528)
  • WB

Lab

Western blot - Anti-YKL-40/CHI3L1 antibody (AB77528)

False colour image of Western blot : Anti-YKL-40/CHI3L1 antibody staining at 1 ug/ml, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab77528 was shown to bind specifically to YKL-40/CHI3L1. A band was observed at 33-42 kDa in wild-type THP-1 cell lysates with no signal observed at this size in CHI3L1 knockout cell line ab280038 (knockout cell lysate ab280097). To generate this image, wild-type and CHI3L1 knockout THP-1 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.

All lanes:

Western blot - Anti-YKL-40/CHI3L1 antibody (ab77528) at 1 µg/mL

Lane 1:

Wild-type THP-1 cell lysate at 20 µg

Lane 2:

CHI3L1 knockout THP-1 cell lysate at 20 µg

Lane 2:

Western blot - Human CHI3L1 knockout THP-1 cell line (<a href='/en-us/products/cell-lines/human-chi3l1-knockout-thp-1-cell-line-ab280038'>ab280038</a>)

Lane 3:

U-87 MG cell lysate at 20 µg

Lane 4:

Jurkat cell lysate at 20 µg

Predicted band size: 43 kDa

Observed band size: 33-42 kDa

false

Western blot - Anti-YKL-40/CHI3L1 antibody (AB77528)
  • WB

Unknown

Western blot - Anti-YKL-40/CHI3L1 antibody (AB77528)

All lanes:

Western blot - Anti-YKL-40/CHI3L1 antibody (ab77528) at 1 µg/mL

All lanes:

THP1 (Human acute monocytic leukemia cell line) Whole Cell Lysate at 10 µg

Secondary

All lanes:

Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution

Predicted band size: 43 kDa

Observed band size: 45 kDa

true

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

ICC/IF, IHC-P, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

From May 2024, QC testing of replenishment batches of this polyclonal changed. All tested and expected application and reactive species combinations are still covered by our Abcam product promise. However, we no longer test all applications. For more information on a specific batch, please contact our Scientific Support who will be happy to help. You may also be interested in our alternative recombinant antibody, ab255297.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "1 µg/mL", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "5 µg/mL", "ICCIF-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>" }, "Mouse": { "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Orangutan": { "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

YKL-40 also known as chitinase-3-like protein 1 (CHI3L1) is a glycoprotein with a molecular weight of approximately 40 kDa. Scientists often study it for its roles in inflammatory processes. It has expressions in numerous tissues including liver cartilage and the central nervous system. The CHI3L1 protein does not possess chitinase activity unlike other members of the chitinase family yet it interacts with various ligands to influence cellular behavior.
Biological function summary

YKL-40 plays significant roles in tissue remodeling and inflammation. It does not form part of a larger complex by itself but influences several cellular processes. This protein affects cell proliferation migration and survival making it involved in both normal physiological processes and pathological conditions. CHI3L1 also exhibits a connection to the immune response where it modulates macrophage activity and interacts with other immune cells.

Pathways

YKL-40 is integral to the inflammatory and extracellular matrix pathways. It associates with proteins such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) influencing signaling cascades that modulate inflammation. Through these interactions CHI3L1 becomes a mediator of connective tissue metabolism and immune reactions in various pathophysiological states.

YKL-40 shows strong links to conditions like osteoarthritis and certain cancers. In osteoarthritis elevated levels of CHI3L1 reflect increased cartilage degradation while in oncology it correlates with tumor angiogenesis and metastasis potential. Its connection with proteins such as matrix metalloproteinases highlights its role in disease mechanisms highlighting its potential as a biomarker for early detection and disease progression monitoring.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Carbohydrate-binding lectin with a preference for chitin. Has no chitinase activity. May play a role in tissue remodeling and in the capacity of cells to respond to and cope with changes in their environment. Plays a role in T-helper cell type 2 (Th2) inflammatory response and IL-13-induced inflammation, regulating allergen sensitization, inflammatory cell apoptosis, dendritic cell accumulation and M2 macrophage differentiation. Facilitates invasion of pathogenic enteric bacteria into colonic mucosa and lymphoid organs. Mediates activation of AKT1 signaling pathway and subsequent IL8 production in colonic epithelial cells. Regulates antibacterial responses in lung by contributing to macrophage bacterial killing, controlling bacterial dissemination and augmenting host tolerance. Also regulates hyperoxia-induced injury, inflammation and epithelial apoptosis in lung.
See full target information CHI3L1

Publications (39)

Recent publications for all applications. Explore the full list and refine your search

Science advances 11:eadv1492 PubMed40680137

2025

CHI3L1/YKL-40 signaling inhibits neurogenesis in models of Alzheimer's disease.

Applications

Unspecified application

Species

Unspecified reactive species

Xin Yang,Wei Jiang,Yuhan Li,Chun Geun Lee,Jack A Elias,Changyong Tang,Yu-Wen Alvin Huang

EBioMedicine 118:105833 PubMed40580577

2025

Comprehensive immune ageing reveals TREM2/TIM3 myeloid cells drive brain immune evasion.

Applications

Unspecified application

Species

Unspecified reactive species

Berta Segura-Collar,Lucia Mondejar-Ruescas,Denisse Alcivar-López,María Garranzo-Asensio,Pablo Mata-Martinez,Ramón Garcia-Escudero,Aurelio Hernández-Laín,Juan M Sepúlveda,Ángel Pérez Nuñez,Jesús Avila,Pilar Sánchez-Gómez,Ricardo Gargini

Allergologia et immunopathologia 53:88-97 PubMed40342118

2025

Dieckol ameliorates inflammatory response via inhibition of CHI3L1 expression in collagen-induced arthritis rats.

Applications

Unspecified application

Species

Unspecified reactive species

Weijiang Wang,Huijie Li

Scientific reports 15:5049 PubMed39934637

2025

A novel lncRNA enhances autophagy to suppress extracellular matrix via modulating TP53INP1 in human trabecular meshwork cells under oxidative stress.

Applications

Unspecified application

Species

Unspecified reactive species

Jinjun Tie,Junhong Guo,Yijia Huang,Zihan Huang,Zhichao Yan,Jiemei Yuan,Xiaoli Shen,Jiantao Wang

Nature communications 16:471 PubMed39773984

2025

Endothelial-secreted Endocan activates PDGFRA and regulates vascularity and spatial phenotype in glioblastoma.

Applications

Unspecified application

Species

Unspecified reactive species

Soniya Bastola,Marat S Pavlyukov,Neel Sharma,Yasmin Ghochani,Mayu A Nakano,Sree Deepthi Muthukrishnan,Sang Yul Yu,Min Soo Kim,Alireza Sohrabi,Natalia P Biscola,Daisuke Yamashita,Ksenia S Anufrieva,Tatyana F Kovalenko,Grace Jung,Tomas Ganz,Beatrice O'Brien,Riki Kawaguchi,Yue Qin,Stephanie K Seidlits,Alma L Burlingame,Juan A Oses-Prieto,Leif A Havton,Steven A Goldman,Anita B Hjelmeland,Ichiro Nakano,Harley I Kornblum

Iranian journal of biotechnology 22:e3693 PubMed39737205

2024

Inhibition of Chitinase-3-like Protein 1 Reduced Epithelial-Mesenchymal Transition and Vascular Epithelial Cadherin Expression in Oesophageal Squamous Cell Carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Yanzi Qin,Wenjun Zhao,Qicai Li,Zhaogeng Cai,Guowen Wang,Nan Wang,Li Ma

International journal of molecular sciences 25: PubMed39408927

2024

YKL40/Integrin β4 Axis Induced by the Interaction between Cancer Cells and Tumor-Associated Macrophages Is Involved in the Progression of High-Grade Serous Ovarian Carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Keitaro Yamanaka,Yu-Ichiro Koma,Satoshi Urakami,Ryosuke Takahashi,Satoshi Nagamata,Masaki Omori,Rikuya Torigoe,Hiroki Yokoo,Takashi Nakanishi,Nobuaki Ishihara,Shuichi Tsukamoto,Takayuki Kodama,Mari Nishio,Manabu Shigeoka,Hiroshi Yokozaki,Yoshito Terai

Cell reports. Medicine 5:101582 PubMed38781959

2024

Single-cell multiomics profiling reveals heterogeneous transcriptional programs and microenvironment in DSRCTs.

Applications

Unspecified application

Species

Unspecified reactive species

Clémence Henon,Julien Vibert,Thomas Eychenne,Nadège Gruel,Léo Colmet-Daage,Carine Ngo,Marlène Garrido,Nicolas Dorvault,Maria Eugenia Marques Da Costa,Virginie Marty,Nicolas Signolle,Antonin Marchais,Noé Herbel,Asuka Kawai-Kawachi,Madison Lenormand,Clémence Astier,Roman Chabanon,Benjamin Verret,Rastislav Bahleda,Axel Le Cesne,Fatima Mechta-Grigoriou,Matthieu Faron,Charles Honoré,Olivier Delattre,Joshua J Waterfall,Sarah Watson,Sophie Postel-Vinay

Nature communications 15:968 PubMed38320988

2024

A clinically applicable connectivity signature for glioblastoma includes the tumor network driver CHI3L1.

Applications

Unspecified application

Species

Unspecified reactive species

Ling Hai,Dirk C Hoffmann,Robin J Wagener,Daniel D Azorin,David Hausmann,Ruifan Xie,Magnus-Carsten Huppertz,Julien Hiblot,Philipp Sievers,Sophie Heuer,Jakob Ito,Gina Cebulla,Alexandros Kourtesakis,Leon D Kaulen,Miriam Ratliff,Henriette Mandelbaum,Erik Jung,Ammar Jabali,Sandra Horschitz,Kati J Ernst,Denise Reibold,Uwe Warnken,Varun Venkataramani,Rainer Will,Mario L Suvà,Christel Herold-Mende,Felix Sahm,Frank Winkler,Matthias Schlesner,Wolfgang Wick,Tobias Kessler

Scientific reports 13:19172 PubMed37932407

2023

YKL-40 serum levels are predicted by inflammatory state, age and diagnosis of idiopathic inflammatory myopathies.

Applications

Unspecified application

Species

Unspecified reactive species

Mónica Vázquez-Del Mercado,Felipe Pérez-Vázquez,Ana L Márquez-Aguirre,Erika-Aurora Martínez-García,Efrain Chavarria-Avila,Carlos G Ramos-Becerra,Andrea Aguilar-Vázquez,Marisol Godínez-Rubí,Beatriz-Teresita Martín-Márquez,Livier Gómez-Limón,Guillermo Márquez-De-La-Paz,Edy-David Rubio-Arellano,Oscar Pizano-Martinez
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com